Apellis Pharmaceuticals Net Foreign Currency Exchange Gain/Loss (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

25.31 +0.75 (+3.05%) USD | NASDAQ | Dec 16, 16:00

25.31 0.00 (0.00%) After-Hours: 19:41

View Net Foreign Currency Exchange Gain/Loss (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	--
Amicus Therapeutics, Inc.	Upgrade
Fortress Biotech, Inc.	--
Ultragenyx Pharmaceutical, Inc.	--
Fulcrum Therapeutics, Inc.	--